Cargando…
Pregabalin inhibits proinflammatory cytokine release in patients with fibromyalgia syndrome
OBJECTIVES: The main goal of the study was to investigate how pregabalin (PGB) affects proinflammatory cytokine release in patients with fibromyalgia syndrome (FMS). PATIENTS AND METHODS: This experimental research study was conducted with 85 female participants (mean age: 49.6±10.1 years; range, 30...
Autores principales: | Ellergezen, Pınar, Alp, Alev, Çavun, Sinan, Çelebi, Melih, Macunluoğlu, Aslı Ceren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish League Against Rheumatism
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481681/ https://www.ncbi.nlm.nih.gov/pubmed/37680505 http://dx.doi.org/10.46497/ArchRheumatol.2023.9517 |
Ejemplares similares
-
Pregabalin for the management of fibromyalgia syndrome
por: Boomershine, Chad S
Publicado: (2010) -
Pregabalin in Treatment-Refractory Fibromyalgia
por: Stacey, Brett R, et al.
Publicado: (2010) -
Evaluation of patellar tendon with shear wave elastography after anterior cruciate ligament reconstruction using hamstring tendons
por: Alp, Nazmi Bülent, et al.
Publicado: (2020) -
Proinflammatory cytokine levels in fibromyalgia patients are independent of body mass index
por: Hernandez, Maria E, et al.
Publicado: (2010) -
Proinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal status
por: Sturgeon, John A, et al.
Publicado: (2014)